Evidence map›Paper›PMID 40702033›Full record

ArticleScientific reports2025

Early and non-destructive prediction of the differentiation efficiency of human induced pluripotent stem cells using imaging and machine learning.

Miki Arai Hojo, Taku Tsuzuki, Yosuke Ozawa, Toshiyuki Araki, Hidetoshi Sakurai

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Miki Arai Hojo *Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan. miki.a.hojo@gmail.com.
Taku Tsuzuki *Epistra Inc, Tokyo, Japan.
Yosuke OzawaEpistra Inc, Tokyo, Japan. ozawaysk@epistra.jp.
Toshiyuki ArakiDepartment of Peripheral Nervous System Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.
Hidetoshi SakuraiDepartment of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan. hsakurai@cira.kyoto-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The reproducibility and robustness of many directed differentiation protocols from human induced pluripotent stem cells (hiPSCs) remain low, and the long differentiation induction period significantly limits protocol optimization. To address this, we developed an early and non-destructive prediction system for the differentiation induction efficiency of hiPSCs using bioimage informatics. We employed a directed differentiation protocol for muscle stem cells (MuSCs), a promising cell source for the regenerative therapy of muscular dystrophy. Biological analyses suggested that days 14-38 are positive for forecasting the induction efficiency on day 82. Therefore, we conducted six independent experiments, inducing MuSC differentiation in a total of 34 wells, and captured a total of 5,712 phase contrast cell images between days 14 and 38. We selected Fast Fourier transform (FFT) as the feature extraction method and confirmed that it captures the characteristics of cells during differentiation. By classifying images on each day using extracted features and machine learning, we found that samples with high and low induction efficiency could be predicted at approximately 50 days before the end of induction. This system is expected to contribute to regenerative therapy through effective protocol optimization.

Indexed as

Cell DifferentiationInduced Pluripotent Stem CellsMachine LearningHumansImage Processing, Computer-AssistedBioimage informaticsDirected differentiationEarly and non-destructive predictionHuman induced pluripotent stem cells (hiPSCs)Machine learningMuscle stem cells (MuSCs)

Identifiers

PMID40702033
PMCPMC12287433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.